Завершено
Фаза II
Беларусь
Gemcitabine; ELENAGEN · CureLab Oncology
Open Label Randomized Clinical Study of Plasmid Encoding p62/SQSTM1 (ELenagen) in in Combination With Gemcitabine in Patients With Platinum-resistant Ovarian Cancer